Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $497.50M.
ENTERPRISE VALUE (EV)
$497.50M
Delcath Systems, Inc.
Market Cap
$540.95M
Enterprise Value (EV)
$497.50M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Delcath Systems, Inc. (DCTH) | $540.95M | $497.50M |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | $314.09M |
| ProKidney Corp. (PROK)vs › | $538.01M | $466.66M |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $537.18M | $521.82M |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | $483.15M |
| Crescent Biopharma, Inc. (CBIO)vs › | $525.22M | $355.06M |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | $534.71M |
| Monopar Therapeutics Inc. (MNPR)vs › | $524.20M | $471.55M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $558.65M | $539.49M |
| Altimmune, Inc. (ALT)vs › | $522.16M | $494.86M |
Market Cap
$540.95M
Total Debt
$0.00
Cash
$43.45M
Enterprise Value
$497.50M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
